Ahmed M. Senan
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research 2
- COVID-19 Clinical Research Studies 2
- Neurology top 10%
- Biomedical Engineering top 10%
- Modeling and Simulation top 10%
- Biotechnology top 10%
- Microbial Inactivation Methods 4
-
- Plasma Applications and Diagnostics 3
-
- Catalysis and Hydrodesulfurization Studies 3
-
- Glycosylation and Glycoproteins Research 2
-
- Catalytic C–H Functionalization Methods 2
- Catalytic Cross-Coupling Reactions 2
- Co-authors
- Jonathan HerskovitzMahmudul HasanJatin MachhiHoward E. GendelmanBhavesh D. KevadiyaMilankumar PatelWilson R. BlombergMaxim Oleynikov
- Partner nations
- ChinaUnited StatesTürkiye
In The Last Decade
Ahmed M. Senan
25 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Infectious Diseases 628
- Neurology 141
- Biomedical Engineering 347
- Modeling and Simulation 36
- Biotechnology 59
Countries citing papers authored by Ahmed M. Senan
This map shows the geographic impact of Ahmed M. Senan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmed M. Senan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmed M. Senan more than expected).
Fields of papers citing papers by Ahmed M. Senan
This network shows the impact of papers produced by Ahmed M. Senan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmed M. Senan. The network helps show where Ahmed M. Senan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ahmed M. Senan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 14 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 18 | |
| 8 | 2023 | 6 | |
| 9 | 2022 | 11 | |
| 10 | 2022 | 55 | |
| 11 | 2021 | 5 | |
| 12 | Diagnostics for SARS-CoV-2 infectionsbreakdown → | 2021 | 585 |
| 13 | 2021 | 6 | |
| 14 | 2020 | 27 | |
| 15 | 2020 | 406 | |
| 16 | 2019 | 45 | |
| 17 | 2019 | 41 | |
| 18 | 2019 | 6 | |
| 19 | 2017 | 3 | |
| 20 | 2017 | 45 |
About Ahmed M. Senan
Ahmed M. Senan is a scholar working on Biotechnology, Process Chemistry and Technology and Organic Chemistry, having authored 25 papers that have together received 1.4k indexed citations. Recurring topics across this work include Microbial Inactivation Methods (4 papers), Plasma Applications and Diagnostics (3 papers), Catalysis and Hydrodesulfurization Studies (3 papers), Glycosylation and Glycoproteins Research (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Catalytic C–H Functionalization Methods (2 papers), Catalytic Cross-Coupling Reactions (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Infectious Diseases (628 citations), Neurology (141 citations) and Biomedical Engineering (347 citations). Ahmed M. Senan has collaborated with scholars based in China, United States and Türkiye. Frequent co-authors include Jonathan Herskovitz, Mahmudul Hasan, Jatin Machhi, Howard E. Gendelman, Bhavesh D. Kevadiya, Milankumar Patel, Wilson R. Blomberg, Maxim Oleynikov, Linda Chang and Chamindie Punyadeera.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.